Inhibition of proto-oncogene c-Src tyrosine kinase: toward a new antiarrhythmic strategy?
- PMID: 24412447
- PMCID: PMC4469261
- DOI: 10.1016/j.jacc.2013.10.082
Inhibition of proto-oncogene c-Src tyrosine kinase: toward a new antiarrhythmic strategy?
Abstract
Cellular-Src (c-Src) encodes a plasma membrane-associated tyrosine protein kinase, which plays a vital role in signaling pathways related to cellular development and carcinogenesis (1,2). It was the first proto-oncogene to be described and is the cellular homologue in humans of the viral oncogene of Rous sarcoma virus, the chicken tumor virus discovered by Peyton Rous in 1911 (3). More recently, c-Src has been implicated in connexin43 (Cx43) remodeling in epicardial border zone myocytes following myocardial infarction (MI) (4).
Keywords: Src; connexin43; gap junctions; myocardial infarction; sudden death.
Figures

Comment on
-
c-Src kinase inhibition reduces arrhythmia inducibility and connexin43 dysregulation after myocardial infarction.J Am Coll Cardiol. 2014 Mar 11;63(9):928-34. doi: 10.1016/j.jacc.2013.10.081. Epub 2014 Jan 8. J Am Coll Cardiol. 2014. PMID: 24361364 Free PMC article.
References
-
- Roskoski R., Jr Src protein-tyrosine kinase structure and regulation. Biochem Biophys Res Commun. 2004;324:1155–64. - PubMed
-
- Roskoski R., Jr Src kinase regulation by phosphorylation and dephosphorylation. Biochem Biophys Res Commun. 2005;331:1–14. - PubMed
-
- Martin GS. The hunting of the Src. Nat Rev Mol Cell Biol. 2001;2:467–75. - PubMed
-
- Beyer EC, Paul DL, Goodenough DA. Connexin family of gap junction proteins. J Membr Biol. 1990;116:187–94. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous